Cancer Treatment
Studies from the United Kingdom, People's Republic of China and Belgium add new findings to cancer treatment body of knowledge
Published in Cancer Weekly, June 19th, 2006
Study 1: CpG oligodeoxynucleotides (ODN) activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT-derived modified cryptic MHC class I-restricted epitope.
According to recent research from France, "The use of synthetic peptides derived from tumor-associated antigens is attractive for the development of antitumoral vaccines as far as strong adjuvants are found to render them immunogenic. We investigated the possibility to enhance the CD8 response against the human and mouse shared...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-06-19)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer risk not associated with use of antidepressant medications - Cancer Programs
Cancer education and detection programs warranted in inner city communities - Neuroendocrine Tumors
Delivered tumor dose for neuroendocrine tumors increased by combining I-131-MIBG with Y-90-DOTATOC - Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma susceptibility predicted by haplotypes in TNF region - Thyroid Cancer
MACIS prognostic system was efficacious in predicting outcome of papillary thyroid carcinoma - Acute Myeloid Leukemia Prognosis
MAC-1 (CD11b) expression in acute myeloid leukemia associated with unfavorable prognosis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
